CYP2D6 isoenzyme and ABCB1 gene polymorphisms associated with postoperative nausea and vomiting in women undergoing laparoscopic cholecystectomy: a randomized trial

[1]  I. Cavalcanti,et al.  Comparative Study Between Fosaprepitant and Palonosetron in the Prophylaxis of Postoperative Nausea and Vomiting in Women Undergoing Laparoscopic Cholecystectomy: Prospective, Randomized and Double-Blind Study , 2022, Frontiers in Pharmacology.

[2]  U. Frey,et al.  Genetic variability in postoperative nausea and vomiting , 2020, European journal of anaesthesiology.

[3]  F. Stüber,et al.  A serotonin transporter polymorphism is associated with postoperative nausea and vomiting: An observational study in two different patient cohorts. , 2019, European journal of anaesthesiology.

[4]  I. Cavalcanti,et al.  Use of palonosetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in women 60 years of age or older undergoing laparoscopic cholecystectomy: A randomised double-blind study. , 2019, European journal of anaesthesiology.

[5]  U. Frey,et al.  CHRM3 rs2165870 polymorphism is independently associated with postoperative nausea and vomiting, but combined prophylaxis is effective , 2018, British journal of anaesthesia.

[6]  J. L. Aguayo-Albasini,et al.  Genetic Factors Associated with Postoperative Nausea and Vomiting: a Systematic Review , 2018, Journal of Gastrointestinal Surgery.

[7]  E. Flowers,et al.  A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting. , 2018, Critical reviews in oncology/hematology.

[8]  S. Choi,et al.  Comparison of Ramosetron and Palonosetron for Preventing Nausea and Vomiting after Spinal Surgery: Association With ABCB1 Polymorphisms , 2017, Journal of neurosurgical anesthesiology.

[9]  S. Choi,et al.  Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting , 2015, Yonsei medical journal.

[10]  Fan Zhou,et al.  Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting. , 2014, Clinical therapeutics.

[11]  I. Bala,et al.  Comparison of palonosetron with palonosetron-dexamethasone combination for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. , 2014, Minerva anestesiologica.

[12]  S. Bergese,et al.  Consensus Guidelines for the Management of Postoperative Nausea and Vomiting , 2014, Anesthesia and analgesia.

[13]  P. Borst,et al.  P-glycoprotein ABCB1: a major player in drug handling by mammals. , 2013, The Journal of clinical investigation.

[14]  A. Hazra,et al.  Evaluation of antiemetic effect of intravenous palonosetron versus intravenous ondansetron in laparoscopic cholecystectomy: A randomized controlled trial , 2013, Indian journal of pharmacology.

[15]  M. Ingelman-Sundberg,et al.  Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database. , 2013, Methods in molecular biology.

[16]  A. Rudra,et al.  Current Concepts in the Management of Postoperative Nausea and Vomiting , 2011, Anesthesiology research and practice.

[17]  J. Nortier,et al.  Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy. , 2011, Japanese journal of clinical oncology.

[18]  Marek Postula,et al.  Genome-wide Association Study Using Pooled DNA to Identify Candidate Markers Mediating Susceptibility to Postoperative Nausea and Vomiting , 2011, Anesthesiology.

[19]  P. Nagele.  Perioperative genomics. , 2011, Best practice & research. Clinical anaesthesiology.

[20]  S. H. Lee,et al.  Association of ABCB1 polymorphisms with the efficacy of ondansetron for postoperative nausea and vomiting , 2010, Anaesthesia.

[21]  P. White,et al.  The Impact of Current Antiemetic Practices on Patient Outcomes: A Prospective Study on High-Risk Patients , 2008, Anesthesia and analgesia.

[22]  T. Gan,et al.  Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting , 2006, Current opinion in anaesthesiology.

[23]  T. Gan,et al.  Risk Factors for Postoperative Nausea and Vomiting , 2006, Anesthesia and analgesia.

[24]  M. Babaoğlu,et al.  Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5‐hydroxytryptamine type 3 antagonists , 2005, Clinical pharmacology and therapeutics.

[25]  Stuart J Pocock,et al.  Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study , 2004, BMJ : British Medical Journal.

[26]  N. Roewer,et al.  Risk Assessment of Postoperative Nausea and Vomiting , 2003, International anesthesiology clinics.

[27]  T. Iga,et al.  Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population. , 2002, Mutation research.

[28]  E. Oren,et al.  Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. , 2001, JAMA.

[29]  D. Lubarsky,et al.  How Much Are Patients Willing to Pay to Avoid Postoperative Nausea and Vomiting? , 2001, Anesthesia and analgesia.